Skip to main content
. 2006 Sep 7;1:27. doi: 10.1186/1745-6150-1-27

Table 4.

Summary of values of the coefficients of standard deviation function and Kα coefficients

GeneChip/average/SD/CV No. of probe sets Cons. samp. size No. of arrays No. of comp. Coefficient. of st. dev. function Average Kalpha values in given probability intervals

a1 a2 0.500 0.600 0.700 0.800 0.900 0.950 0.990 0.995
Total average [sum] [682] [900] 9.66 0.266 0.642 0.808 1.009 1.275 1.711 2.145 3.226 3.741
Total SD 9.99 0.146 0.033 0.039 0.043 0.045 0.052 0.080 0.270 0.390
Total CV 1.03 0.550 0.052 0.049 0.043 0.035 0.030 0.037 0.084 0.104

HuGeneFL [a1] 7070 12 11 54 8.61 0.115 0.64 0.81 1.01 1.27 1.71 2.16 3.41 4.09
HuGeneFL [b] 7070 12 13 78 8.09 0.418 0.61 0.77 0.97 1.24 1.73 2.24 3.58 4.18
HuGeneFL [c] 7070 25 5 10 34.58 0.435 0.61 0.76 0.94 1.20 1.60 2.03 3.39 4.10
HuGeneFL [c] 7070 25 5 10 28.93 0.393 0.59 0.73 0.92 1.18 1.60 2.07 3.42 4.07

HuGeneFL avg [sum] [34] [152] 20.05 0.34 0.61 0.77 0.96 1.22 1.66 2.13 3.45 4.11
HuGeneFL SD 13.71 0.15 0.02 0.03 0.04 0.04 0.07 0.10 0.09 0.05
HuGeneFL CV 0.68 0.44 0.04 0.04 0.04 0.04 0.04 0.05 0.03 0.01

HG-U95Av2 [d] 12559 12 5 10 6.30 0.688 0.61 0.78 1.00 1.30 1.83 2.32 2.98 3.26
HG-U95Av2 [e1] 12559 25 15 15 10.49 0.199 0.65 0.82 1.01 1.27 1.68 2.07 3.05 3.55
HG-U95Av2 [e2] 12559 25 15 15 10.59 0.200 0.64 0.81 1.01 1.26 1.67 2.07 3.07 3.56
HG-U95Av2 [e3] 12559 25 15 15 10.41 0.189 0.63 0.80 1.00 1.25 1.66 2.07 3.06 3.55
HG-U95Av2 [e4] 12559 25 12 12 10.91 0.185 0.63 0.79 0.99 1.24 1.66 2.04 3.02 3.50
HG-U95Av2 [e5] 12559 25 4 2 6.50 0.394 0.65 0.82 1.01 1.26 1.65 2.05 3.05 3.62
HG-U95Av2 [f] 12559 25 4 2 5.64 0.155 0.64 0.81 1.00 1.25 1.66 2.04 2.92 3.31
HG-U95Av2 [g1] 12559 25 2 1 4.79 0.479 0.61 0.76 0.95 1.20 1.64 2.10 3.22 3.71
HG-U95Av2 [g1] 12559 25 5 10 3.31 0.500 0.64 0.80 1.00 1.26 1.69 2.09 2.98 3.29

HG-U95Av2 avg [sum] [77] [82] 7.66 0.33 0.63 0.80 1.00 1.26 1.68 2.09 3.04 3.48
HG-U95Av2 SD 2.94 0.19 0.02 0.02 0.02 0.03 0.06 0.09 0.08 0.16
HG-U95Av2 CV 0.38 0.57 0.02 0.02 0.02 0.02 0.04 0.04 0.03 0.05

HG-U95B [d] 12563 12 5 10 16.26 0.636 0.63 0.80 1.01 1.30 1.80 2.28 3.18 3.68
HG-U95B [e5] 12563 25 2 1 17.95 0.167 0.64 0.80 0.99 1.24 1.65 2.02 3.08 3.54
HG-U95C [d] 12587 12 5 10 20.57 0.603 0.64 0.81 1.02 1.30 1.77 2.25 3.39 3.98
HG-U95C [e5] 12587 25 2 1 16.42 0.178 0.63 0.79 0.99 1.23 1.62 2.00 3.06 3.61
HG-U95D [d] 12587 12 5 10 39.79 0.501 0.62 0.78 0.99 1.28 1.77 2.33 3.80 4.42
HG-U95D [e5] 12587 25 2 1 54.45 0.240 0.63 0.79 0.99 1.23 1.62 2.05 2.98 3.48
HG-U95E [d] 12582 12 5 10 31.84 0.534 0.60 0.76 0.97 1.27 1.78 2.29 3.53 4.08
HG-U95E [e5] 12582 25 2 1 45.64 0.215 0.63 0.79 1.00 1.25 1.64 2.02 2.88 3.31

HG-U95B to E avg [sum] [28] [44] 30.37 0.38 0.63 0.79 0.99 1.26 1.71 2.16 3.24 3.76
HG-U95B to E SD 14.87 0.20 0.01 0.01 0.02 0.03 0.08 0.14 0.31 0.37
HG-U95B to E CV 0.49 0.53 0.02 0.02 0.02 0.02 0.05 0.07 0.10 0.10

HG-U133A 2.0 [e6] 22225 25 15 15 4.55 0.091 0.65 0.82 1.02 1.28 1.72 2.14 3.14 3.62
HG-U133A 2.0 [e7] 22225 25 15 15 4.50 0.106 0.66 0.84 1.04 1.31 1.75 2.17 3.18 3.63
HG-U133A 2.0 [e8] 22225 25 12 12 4.10 0.108 0.67 0.84 1.05 1.32 1.77 2.21 3.26 3.75
HG-U133A 2.0 [h1] 22225 25 8 4 3.91 0.288 0.64 0.80 1.00 1.26 1.67 2.08 3.05 3.54
HG-U133A 2.0 [i1] 22225 12 4 6 6.25 0.210 0.65 0.82 1.01 1.27 1.68 2.08 3.04 3.48
HG-U133A 2.0 [j] 22225 25 5 10 6.54 0.390 0.62 0.79 0.98 1.25 1.68 2.10 3.13 3.62
HG-U133A 2.0 [j] 22225 25 5 10 5.54 0.393 0.62 0.79 0.98 1.25 1.66 2.08 3.10 3.64
HG-U133A 2.0 [k1] 22225 25 6 15 3.68 0.672 0.63 0.80 1.00 1.27 1.71 2.11 2.84 3.16
HG-U133A 2.0 [k1] 22225 25 3 3 4.95 0.435 0.59 0.74 0.93 1.19 1.65 2.15 3.37 3.79
HG-U133A 2.0 [l1] 22225 25 6 3 6.45 0.151 0.64 0.81 1.01 1.27 1.68 2.08 3.06 3.55
HG-U133A 2.0 [l2] 22225 25 12 6 6.78 0.148 0.65 0.82 1.02 1.27 1.67 2.06 2.93 3.33

HG-U133A 2.0 avg [sum] [91] [99] 5.21 0.27 0.64 0.80 1.00 1.27 1.69 2.11 3.10 3.56
HG-U133A 2.0 SD 1.15 0.18 0.02 0.03 0.03 0.03 0.04 0.05 0.15 0.18
HG-U133A 2.0 CV 0.22 0.67 0.03 0.03 0.03 0.03 0.02 0.02 0.05 0.05

HG-U133 Plus 2 [i2] 54000 50 8 10 3.94 0.188 0.68 0.85 1.06 1.33 1.76 2.17 3.11 3.55
HG-U133 Plus 2 [l3] 54000 50 20 27 4.03 0.086 0.65 0.82 1.02 1.28 1.69 2.07 2.95 3.34

HG-U133 Plus 2 avg [sum] [28] [37] 3.99 0.14 0.67 0.83 1.04 1.30 1.72 2.12 3.03 3.44

HG-Focus [k2] 8756 12 9 36 4.13 0.216 0.70 0.87 1.08 1.35 1.76 2.15 3.06 3.47
HG-Focus [k2] 8756 12 4 6 4.13 0.181 0.68 0.86 1.07 1.33 1.76 2.18 3.08 3.56
HG-Focus [k2] 8756 12 4 6 3.90 0.198 0.70 0.87 1.08 1.36 1.81 2.22 3.15 3.55
HG-Focus [k2] 8756 12 4 6 3.69 0.176 0.68 0.86 1.07 1.35 1.79 2.19 3.17 3.64
HG-Focus [k2] 8756 12 5 10 3.46 0.183 0.67 0.85 1.05 1.33 1.77 2.19 3.12 3.49
HG-Focus [k2] 8756 12 4 6 4.01 0.205 0.71 0.89 1.10 1.38 1.81 2.19 3.11 3.53
HG-Focus [k2] 8756 12 4 6 3.98 0.174 0.68 0.85 1.06 1.32 1.74 2.14 3.06 3.43

HG-Focus avg [sum] [34] [76] 3.90 0.19 0.69 0.86 1.07 1.35 1.78 2.18 3.11 3.52
HG-Focus SD 0.24 0.02 0.01 0.02 0.02 0.02 0.03 0.03 0.04 0.07
HG-Focus CV 0.06 0.08 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.02

MG-Mu11kSubA, SubB [a] 13069 12 10 20 9.98 0.121 0.59 0.75 0.95 1.22 1.70 2.20 3.65 4.48
MG-Mu11kSubA, SubB [a] 13069 12 10 20 8.03 0.170 0.59 0.74 0.94 1.20 1.68 2.19 3.78 4.66
MG-Mu11kSubA, SubB [a] 13069 12 10 20 8.21 0.145 0.60 0.76 0.96 1.23 1.70 2.21 3.70 4.52
MG-Mu11kSubA, SubB [a] 13069 12 10 20 5.32 0.139 0.56 0.71 0.91 1.19 1.71 2.30 4.03 4.84
MG-Mu11kSubA, SubB [m1] 13069 12 8 4 13.86 0.321 0.64 0.81 1.01 1.28 1.73 2.22 3.62 4.24
MG Mu11kSubA, SubB [n1] 13069 12 20 10 11.84 0.420 0.66 0.82 1.01 1.26 1.71 2.21 3.61 4.32

MG-Mu11kSubA, SubB avg [sum] [68] [94] 9.54 0.219 0.61 0.77 0.96 1.23 1.70 2.22 3.73 4.51
MG-Mu11kSubA, SubB SD 3.03 0.122 0.04 0.04 0.04 0.04 0.02 0.04 0.16 0.22
MG-Mu11kSubA, SubB CV 0.32 0.557 0.06 0.05 0.04 0.03 0.01 0.02 0.04 0.05

Mu19kSubA, B, C [m2] 12420 12 12 6 15.41 0.314 0.63 0.79 0.99 1.25 1.73 2.26 3.95 4.56

MG-U74Av2 [o] 12588 12 6 6 8.72 0.180 0.59 0.75 0.95 1.23 1.70 2.20 3.56 4.30
MG-U74Av2 [o] 12588 12 5 4 6.97 0.230 0.58 0.74 0.94 1.23 1.71 2.24 3.68 4.48
MG-U74Av2 [p] 12588 12 7 21 9.50 0.125 0.59 0.75 0.95 1.24 1.72 2.21 3.54 4.30
MG-U74Av2 [q] 12588 12 5 4 4.97 0.229 0.68 0.85 1.06 1.33 1.76 2.19 3.23 3.76
MG-U74Av2 [l4] 12588 12 9 9 7.50 0.111 0.67 0.83 1.03 1.30 1.73 2.13 3.09 3.53
MG-U74Av2 [r] 12588 12 10 20 4.69 0.269 0.65 0.82 1.02 1.29 1.73 2.17 3.31 3.89
MG-U74Av2 [r] 12588 12 3 3 3.30 0.238 0.64 0.80 1.00 1.27 1.71 2.17 3.48 4.04
MG-U74Av2 [e5] 12588 12 2 1 3.83 0.184 0.64 0.81 1.00 1.27 1.69 2.10 3.15 3.80
MG-U74Av2 [g2] 12588 12 2 1 13.50 0.451 0.64 0.81 1.01 1.27 1.72 2.16 3.36 3.95
MG U74Av2 [n2] 12400 12 26 13 6.56 0.113 0.64 0.80 1.00 1.27 1.70 2.12 3.15 3.67

MG-U74Av2 avg [sum] [75] [82] 6.96 0.213 0.63 0.80 1.00 1.27 1.72 2.17 3.36 3.97
MG-U74Av2 SD 3.07 0.101 0.03 0.04 0.04 0.03 0.02 0.04 0.20 0.31
MG-U74Av2 CV 0.44 0.472 0.06 0.05 0.04 0.02 0.01 0.02 0.06 0.08

MG-U430A [l5] 22636 25 10 5 7.68 0.132 0.65 0.81 1.01 1.27 1.68 2.06 2.94 3.36
MG-U430A [l6] 22636 25 5 10 10.08 0.265 0.67 0.84 1.04 1.30 1.71 2.10 2.98 3.35
MG-U430A [l6] 22636 25 5 10 9.44 0.160 0.65 0.81 1.01 1.27 1.67 2.05 2.93 3.30

MG-U430A [20] [25] 9.07 0.186 0.65 0.82 1.02 1.28 1.69 2.07 2.95 3.34
MG-U430A 1.24 0.070 0.01 0.02 0.02 0.02 0.02 0.03 0.03 0.03
MG-U430A 0.14 0.377 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01

RG-U34A [h2] 8740 12 35 34 1.82 0.316 0.64 0.81 1.01 1.28 1.73 2.21 3.40 3.95
RG-U34A [l7] 8740 12 6 3 3.25 0.226 0.68 0.85 1.06 1.33 1.76 2.17 3.20 3.77
RG-U34A, [l8] 8740 12 4 2 6.01 0.146 0.65 0.83 1.03 1.29 1.72 2.11 3.10 3.60

RG-U34A avg [sum] [45] [39] 3.70 0.229 0.66 0.83 1.03 1.30 1.74 2.16 3.24 3.78
RG-U34A SD 2.13 0.085 0.02 0.02 0.02 0.02 0.02 0.05 0.15 0.17
RG-U34A CV 0.58 0.371 0.03 0.03 0.02 0.02 0.01 0.02 0.05 0.05

RT-U34 Neurobiology [l7] 982 12 40 20 1.77 0.194 0.60 0.75 0.96 1.22 1.65 2.08 3.12 3.38

Drosophila [s] 13976 12 6 6 2.20 0.081 0.66 0.83 1.04 1.31 1.73 2.17 3.21 3.67

E. coli [t] 7290 12 38 39 3.09 0.337 0.65 0.83 1.04 1.32 1.78 2.24 3.45 4.03
E. coli [u] 7290 12 15 30 1.88 0.302 0.65 0.83 1.04 1.34 1.81 2.29 3.47 4.04

E. Coli avg [sum] [53] [69] 2.23 0.228 0.64 0.81 1.02 1.30 1.74 2.19 3.31 3.78

ATH1 [v1] 22700 25 14 17 9.22 0.307 0.68 0.85 1.05 1.31 1.71 2.09 2.95 3.31
ATH1 [v1] 22700 25 34 36 11.18 0.269 0.68 0.85 1.05 1.31 1.71 2.08 2.91 3.26
ATH1 [w] 22700 25 8 4 6.26 0.279 0.65 0.81 1.01 1.27 1.69 2.10 3.06 3.45
ATH1 [x] 22700 25 4 2 3.09 0.232 0.68 0.85 1.05 1.31 1.72 2.12 3.17 3.70
ATH1 [y] 22700 25 4 2 3.07 0.247 0.66 0.82 1.02 1.28 1.68 2.08 3.09 3.60

ATH1 avg [sum] [64] [61] 6.57 0.267 0.67 0.84 1.04 1.30 1.70 2.09 3.03 3.46
ATH1 SD 3.63 0.029 0.01 0.02 0.02 0.02 0.02 0.02 0.11 0.19
ATH1 CV 0.55 0.108 0.02 0.02 0.02 0.02 0.01 0.01 0.03 0.05

Arabidopsis [v2] 8200 12 7 8 7.69 0.403 0.75 0.94 1.14 1.40 1.79 2.15 2.89 3.18

No. of probe sets is approximate number of the probe sets on array, Cons. samp. size is number of the probe pairs in a consecutive sample, No. of arrays is a number of arrays tested, No. of comp. is the number of pair-wise comparisons among the replicates, coefficients a1 and a2 are the coefficients of standard deviation function and Kalpha is the coefficient determining probability interval; "h." stands for "human," "m." for "murine." Average values, sum of arrays and comparisons (in square brackets), standard deviations (SD) and coefficients of variation (CV) of each GeneChip type are printed in bold italics.

Data sources:

a1 – J. P. Novak et al., HuGeneFl, IMR90 human cell line [10].

a2 – J. P. Novak et al., HuGeneFl, mouse tissues, adult male C57BL/6 [10].

b – A.-M. Mes-Masson, P. Tonin and coworkers, HuGeneFL, normal ovarian surface epithelial (NOSE) primary cell cultures, private communication.

c – P. Permana, HuGeneFL, human skeletal muscle tissue [35].

d – P. Tonin and A.-M. Mes-Masson and coworkers, HG-U95A to E, epithelial ovarian cancer (EOC) cell line [36].

e1 – Affymetrix, HG-U95A, latin square, experiments 1 to 5.

e2 – Affymetrix, HG-U95A, latin square, experiments 6 to 10.

e3 – Affymetrix, HG-U95A, latin square experiments 11 to 15.

e4 – Affymetrix, HG-U95A, latin square, experiments 16 to 19.

e5 – Affymetrix, HG-U95A to E, Demo Data.

e6 – Affymetrix, HG-U133A, latin square, experiments 1 to 5.

e7 – Affymetrix, HG-U133A, latin square, experiments 6 to 10.

e8 – Affymetrix, HG-U133A, latin square, experiments 11 to 14.

f – M. S. Rolph, HG-U95Av2, primary human bronchial epithelial cells.

g1 – Z. Gatalica, HG-U95Av2, breast tumor tissues and normal breast tissue samples [37].

g2 – Z. Gatalica, MG-U74Av2, mouse kidney tissue.

h1 – M. Boerma, HG-U133A 2.0, primary human umbilical vein endothelial cells (HUVECs) and the immortalized HUVEC cell line EA.hy926 [38].

h2 – M. Boerma, RG-U34A, cultures enriched for neonatal rat cardiac myocytes or fibroblasts [39].

i1 – M. Hajduch, HG-U133A 2.0.

i2 – M. Hajduch, HG-U133 plus 2.

j – S. Y. Kim and D. J. Volsky, HG-U133A 2.0, human fetal astrocytes, normal and pseudotyped HIV-1 infected [40].

k1 – O. Modlich, HG-U133A 2.0, human superficial and invasive bladder tumors [41].

k2 – O. Modlich and Raschke, Focus arrays, human lymphoma cell line Kaspas-422, DSMZ no.: ACC 32 (follicular B cell).

l1 – C. Wang and J. Xu, HG-U133A 2.0, human lymphoblast cell line.

l2 – C. Wang and J. Xu, HG-U133A 2.0, human pancreatic islet.

l3 – C. Wang and J. Xu, HG-U133 Plus 2, Stratagene Universal Human Reference RNA, Ambion Human Brain Reference RNA and mixtures of both in different concentrations.

l4 – C. Wang and J. Xu, MG-U74Av2, mouse biliary epithelial cells.

l5 – C. Wang and J. Xu, MG-U430A, mouse spleen.

l6 – C. Wang and J. Xu, MG-U430A, myofibroblast cell line.

l7 – C. Wang and J. Xu, RG-U34A, rat livers.

l8 – C. Wang and J. Xu, RG-U34A, rat bone marrow stem cells.

m1 – McInnes and coworkers, MG-Mu11kSubA, SubB, retinal RNA samples from WT and Rom1 knock-out mice [36].

m2 – McInnes, Szego and coworkers, MG-Mu19kSubA, SubB, SubC, retinal RNA samples from WT and Rom1 knock-out mice [42].

n1 – Burton, McGehee and coworkers, MG-Mu11kSubA, SubB, 3T3-L1 adipocytes [43].

n2 – Burton, McGehee and coworkers, MG-U74Av2,3T3-L1 adipocyte cultures [44].

o – M. Cosio, MG-U74Av2, lung tissues, murine strains NZW and AKR.

p – R. St-Arnaud, MG-U74Av2, C2C12 cells [45].

q – J. Hidalgo, MG-U74Av2, cortex samples, C57B6 normal and IL6 KO mice [46].

r – D. Radzioch, C. Guilbault and coworkers, MG-U74Av2, C57BL/6 (B6) WT and C57BL/6-Cftr-/- (KO) inbred mice [15].

s – S. E. Choe, Drosophila, Drosophila Gene Collection release 1.0 cDNA clones [19].

t – F. Blattner, E. coli antisense genome, E. coli K-12 strain MG1655 and an isogenic fnr::Spr Smr strain [47].

u – J. Slonczewski and S. BonDurant, E. coli antisense genome, E. coli K-12 strain W3110 [48].

v1 – E. Blumwald and J. Sottosanto, ATH1, A. thaliana ecotype Wassilewskija, wild-type line (WS), nhx1 'knockout' line, and a knockout restoration line; [49] and unpublished data.

v2 – E. Blumwald and J. Sottosanto, arabidopsis, A. thaliana ecotype Wassilewskija, wild-type line (WS), and a nhx1 'knockout' line (unpublished data).

w – D. Honys and D. Twell, ATH1, Arabidopsis thaliana ecotype Landsberg erecta plants [50].

x – E. Nambara and K. Nakabayashi, ATH1, Arabidopsis thaliana (L.) Heynh of ecotype Columbia [51].

y – E. Nambara and K. Tatematsu, ATH1, Arabidopsis thaliana (L.) Heynh of ecotype Columbia [52].